Sporadic schwannomas and neurofibromas

References cited
Article section 15 of 16.  Previous  Next

By Herbert B Newton MD

Al-Mefty O, Ayoubi S, Gaber E. Trigeminal schwannomas: removal of dumbbell-shaped tumors through the expanded Meckel cave and outcomes of cranial nerve function. J Neurosurg 2002;96:453-63.

Al Sanosi A, Fagan PA, Biggs ND. Conservative management of acoustic neuroma. Skull Base 2006;16:95-100.

Altuna X, Lopez JP, Yu MA, et al. Potential role of imatinib mesylate (Gleevec, STI-571) in the treatment of vestibular schwannoma. Otol Neurotol 2011;32:163-70.

Ammoun S, Cunliffe CH, Allen JC, et al. ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Neuro Oncol 2010a;12(8):834-43.

Ammoun S, Flaiz C, Ristic N, Schuldt J, Hanemann CO. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. Cancer Res 2008;68(13):5236-45.

Ammoun S, Ristic N, Matthies C, Hilton DA, Hanemann CO. Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244. Neurobiol Dis 2010b;37(1):141-6.

Anderson DE, Leonetti J, Wind JJ, Cribari D, Fahey K. Resection of large vestibular schwannomas: facial nerve preservation in the context of surgical approach and patient-assessed outcome. J Neurosurg 2005;102:643-9.

Anghileri M, Miceli R, Fiore M, et al. Malignant peripheral nerve sheath tumors. Prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006;107:1065-74.

Arbiser JL, Flynn E, Barnhill RL. Analysis of vascularity of human neurofibromas. J Am Acad Dermatol 1998;39:950-4.

Ariel IM. Tumors of the peripheral nervous system. Semin Surg Oncol 1988;4:7-12.

Aryanpur J, Long DM. Schwannoma of the medulla oblongata. J Neurosurg 1988;69:446-9.

Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor. The clinical spectrum and outcome of treatment. Neurol 2003;61(5):696-8.

Bakkouri WE, Kania RE, Guichard JP, Lot G, Herman P, Huy PT. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 2009;110(4):662-9.

Battista RA. Gamma knife radiosurgery for vestibular schwannoma. Otolaryngol Clin North Am 2009;42(4):635-54.

Bederson JB, von Ammon K, Wichmann WW, Yasargil MG. Conservative treatment of patients with vestibular tumors. Neurosurgery 1991;28:646-51.

Bennett ML, Jackson CG, Kaufmann R, Warren F. Postoperative imaging of vestibular schwannomas. Otolaryngol Head Neck Surg 2008;138(5):667-71.

Bentivoglio P, Cheeseman AD, Symon L. Surgical management of acoustic neuromas during the last five years. Part I. Surg Neurol 1988;29:197-204.

Berg JC, Scheithauer BW, Spinner RJ, Allen CM, Koutlas IG. Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region. Hum Pathol 2008;39(5):633-40.

Bianchi AB, Hara T, Ramesh V, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 1994;6:185-92.

Blair KJ, Kiang A, Wang-Rodriguez J, Yu MA, Doherty JK, Ongkeko WM. EGF and bFGF promote invasion that is modulated by PI3/Akt kinase and Erk in vestibular schwannoma. Otol Neurotol 2011;32:308-14.

Brackman DE, Owens RM, Friedman RA, et al. Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000;21:417-24.

Brennan JW, Rowed DW, Nedzelski JM, Chen JM. Cerebrospinal fluid leak after acoustic neuroma surgery: influence of tumor size and surgical approach on incidence and response to treatment. J Neurosurg 2001;94:217-23.

Bruder CE, Ichimura K, Tingby O, et al. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene. Human Genet 1999;104:418-24.

Bulsara KR, Sameshima T, Friedman AH, Fukushima T. Microsurgical management of 53 jugular foramen schwannomas: lessons learned incorporated into a modified grading system. J Neurosurg 2008;109(5):794-803.

Cardillo MR, Filipo R, Monini S, et al. Transforming growth factor-beta1 expression in human acoustic neuroma. Am J Otol 1999;20:65-8.

Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma Cooperative Group. J Clin Oncol 2005;23:8422-30.

Carterlliei M, Swoboda H. Neurofibroma of the auriculotemporal nerve. Eur Arch Otorhinolaryngol 2000;257:396-8.

Casadei GP, Scheithauer BW, Hirose T, Manfrini M, Van Houton C, Wood MB. Cellular schwannoma: a clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients. Cancer 1995;75:1109-19.

Cashen DV, Parisien RC, Raskin K, Hornicek FJ, Gebhardt MC, Mankin HJ. Survival data for patients with malignant schwannoma. Clin Orthop 2004;(426):69-73.

Cayé-Thomasen P, Werther K, Nalla A, et al. VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 2005;26:98-101.

Chang LS, Welling DB. Molecular biology of vestibular schwannomas. Methods Mol Biol 2009;493:163-77.

Chang SD, Poen J, Hancock SL, Martin DP, Adler JR. Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma. Report of two cases. J Neurosurg 1998;89:321-5.

Cho KG, Nagashima T, Barnwell S, Hoshino T. Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms. J Neurosurg 1988;69:588-92.

Chung SY, Kim DI, Lee BH, Yoon PH, Jeon P, Chung TS. Facial nerve schwannomas: CT and MR findings. Yonsei Med J 1998;39:148-53.

Cioffi JA, Yue WY, Mendolia-Loffredo S, Hansen KR, Wackym PA, Hansen MR. MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival. Otol Neurotol 2010;31(9):1455-62.

Clark JJ, Provenzano M, Diggelmann HR, Xu N, Hansen SS, Hansen MR. The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol 2008;29(6):846-53.

Colosimo C, Cerase A, Denaro L, Maira G, Greco R. Magnetic imaging of intramedullary spinal cord schwannomas. Report of two cases and review of the literature. J Neurosurg 2003;99(1 Suppl):114-7.

Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): Long-term results in 106 patients treated in a single institution. Int J Rad Oncol Biol Phys 2005;63:75-81.

Conti P, Pansini G, Mouchaty H, Capuano C, Conti R. Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature. Surg Neurol 2004;61(1):34-43; discussion 44.

Cordan T, Bekar A, Yaman O, Tolunay S. Spinal subarachnoid hemorrhage attributable to schwannoma of the cauda equina. Surg Neurol 1999;51:373-5.

Couturier J, Delattre O, Kujas M, et al. Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analyses. Cancer Genet Cytogenet 1990;45:55-62.

Cruveilhier J. Anatomie pathologique du corps humain. Paris, 1835-1842;2,26:1-8.

Cucchiara RF, Black S, Stachniak J, Layon AJ. Anesthesia and intensive care management of patients with brain tumors. In: Kaye AH, Laws ER, editors. Brain tumors. An encyclopedic approach. Edinburgh: Churchill Livingstone, 1995;14:263-92.

Curtin HD, Hirsch WL. Imaging of acoustic neuromas. Otolaryngol Clin North Am 1992;25:553-607.

Cushing H. Tumors of the nervus acusticus and the syndrome of the CPA. Philadelphia: WB Saunders, 1917.

Demachi H, Takashima T, Kadoya M, et al. MR imaging of spinal neurinomas with pathological correlation. J Comput Assist Tomogr 1990;14:250-4.

Deruaz JP, Janzer RC, Costa J. Cellular schwannomas of the intracranial and intraspinal compartment: morphological and immunological characteristics compared with classical benign schwannomas. J Neuropathol Exp Neurol 1993;52:114-8.

Dewan S, Noren G. Retreatment of vestibular schwannomas with Gamma Knife surgery. J Neurosurg 2008;109 Suppl:144-8.

Dickman CA, Apfelbaum RI. Thoracoscopic microsurgical excision of a thoracic schwannoma. Case report. J Neurosurg 1998;88:898-902.

Di Maio S, Akagami R. Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomas. J Neurosurg 2009;111(4):855-62.

Doherty JK, Ongkeko W, Crawley B, Andalibi A, Ryan AF. ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy. Otol Neurotol 2008;29(1):50-7.

Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-21.

El-Kashlan HK, Zeitoun H, Arts HA, Hoff JT, Telian SA. Recurrence of acoustic neuroma after incomplete resection. Am J Otol 2000;21:389-92.

Erkan EP, Breakfield XO, Saydam O. miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors. Oncotarget 2011;2:265-70.

Evans DGR, Maher ER, Baser ME. Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms. J Med Genet 2005;42:630-2.

Feany MB, Anthony DC, Fletcher CD. Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology 1998;32:405-10.

Ferner RE, Golding JF, Smith M, et al. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol 2008;19(2):390-4.

Ferri GG, Modugno GC, Pirodda A, Fioravanti A, Calbucci F, Ceroni AR. Conservative management of vestibular schwannomas: an effective strategy. Laryngoscope 2008;118(6):951-7.

Fisher MJ, Basu S, Dombi E, et al. The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression. J Neurooncol 2008;87(2):165-71.

Flickinger JC, Kondziolka D, Niranjan A, Lunsford LD. Results of acoustic neuroma radiosurgery: an analysis of 5 years’ experience using current methods. J Neurosurg 2001;94:1-6.

Flickinger JC, Lunsford LD, Coffey RJ, et al. Radiosurgery of acoustic neurinomas. Cancer 1991;67:345-53.**

Flint D, Fagan P, Panarese A. Conservative management of sporadic unilateral acoustic neuromas. J Laryngol Otol 2005;119:424-8.

Fontaine B, Hanson MP, VonSattel JP, Martuza RL, Gusella JF. Loss of chromosome 22 alleles in human sporadic spinal schwannomas. Ann Neurol 1991;29:183-6.

Foote KD, Friedman WA, Buatti JM, Meeks SL, Bova FJ, Kubilis PS. Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 2001;95:440-9.

Forssen UM, Lonn S, Ahlbom A, Savitz DA, Feychting M. Occupational magnetic field exposure and the risk of acoustic neuroma. Am J Ind Med 2006;49:112-8.

Friedman DP, Tartaglino LM, Flanders AE. Intradural schwannomas of the spine: MR findings with emphasis on contrast-enhancement characteristics. AJR Am J Roentgenol 1992;158:1347-50.

Friedman WA, Bradshaw P, Myers A, Bova FJ. Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg 2006;105:657-61.

Fucci MJ, Buchman CA, Brackmann DE, Berliner KI. Acoustic tumor growth: implications for treatment choices. Am J Otol 1999;20:495-9.

Fukaya R, Yoshida K, Ohira T, Kawase T. Trigeminal schwannomas: experience with 57 cases and a review of the literature. Neurosurg Rev 2010;34(2):159-71.

Glasscock MR, Hays JW, Minor LB, Haynes DS, Carrasco VN. Preservation of hearing in surgery for acoustic neuromas. J Neurosurg 1993;78:864-70.

Goksu N, Bayazit Y, Kemaloglu Y. Endoscopy of the posterior fossa and dissection of acoustic neuroma. J Neurosurg 1999;91:76-80.

Gonzalez FL, Ferreira MAT, Zabramski JM, Spetzler RF, Deshmukh P. The middle fossa approach. BNI Quart 2000;16:4-11.**

Gonzalez-Gomez P, Bello MJ, Alonso ME, et al. CpG island methylation in sporadic and neurofibromatosis type 2-associated schwannomas. Clin Cancer Res 2003;9(15):5601-6.

Gupta A, Cohen BH, Ruggieri P, Packer RJ, Phillips PC. Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis I. Neurol 2003;60(1):130-2.

Gupta G, Maniker A. Malignant peripheral nerve sheath tumors. Neurosurg Focus 2007;22:1-8.

Gusella JF, Ramesh V, MacCollin M, Jacoby LB. Merlin: the neurofibromatosis 2 tumor suppressor. Biochim Biophys Acta 1999;1423:M29-36.

Gutmann DH, Giordano MJ, Fishback AS, Guha A. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 1997;49:267-70.

Halliday AL, Sobel RA, Martuza RL. Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 1991;74:248-53.

Hamada K, Tomita Y, Qiu Y, et al. (18)F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors. Skeletal Radiol 2009;38(3):261-6.

Han YY, Kano H, Davis DL, Niranjan A, Lunsford LD. Cell phone use and acoustic neuroma: the need for standardized questionnaires and access to industry data. Surg Neurol 2009;72(3):216-22.

Hanabusa K, Morikawa A, Murata T, Taki W. Acoustic neuroma with malignant transformation. Case report. J Neurosurg 2001;95:518-21.

Hardell L, Carlberg M. Mobile phones, cordless phones and the risk for brain tumours. Int J Oncol 2009;35(1):5-17.

Hardell L, Carlberg M, Mild KH. Case-control study on cellular and cordless telephones and the risk for acoustic neuroma or meningioma in patients diagnosed 2000-2003. Neuroepidemiol 2005;25:120-8.

Hardell L, Carlberg M, Soderqvist F, Hansson Mild K. Meta-analysis of long-term mobile phone use and the association with brain tumours. Int J Oncol 2008;32(5):1097-103.

Hardell L, Mild KH, Sandstrom M, Carlberg M, Hallquist A, Pahlson A. Vestibular schwannoma, tinnitus and cellular telephones. Neuroepidemiol 2003;22:124-9.

Harper CM, Harner SG, Slavit DH, et al. Effect of BAEP monitoring on hearing preservation during acoustic neuroma resection. Neurology 1992;42:1551-3.

Harwalkar JA, Lee JH, Hughes G, et al. Immunoblotting analysis of schwannomin/merlin in human schwannomas. Am J Otol 1998;19:654-9.

Hirokawa Y, Tikoo A, Huynh J, et al. A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J 2004;10(1):20-6.

Hirsch A, Noren G. Audiological findings after stereotactic radiosurgery in acoustic neurinomas. Acta Otolarygol 1988;106:244-51.

Hitotsumatsu T, Iwaki T, Kitamoto T, et al. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol 1997;93:225-32.

Honegger J, Koerbel A, Psaras T, Petrick M, Mueller K. Primary intrasellar schwannoma: clinical, aetiopathological and surgical considerations. Br J Neurosurg 2005;19:432-8.

Hu HP, Huang QL. Signal intensity correlation of MRI with pathological findings in spinal neurinomas. Neuroradiology 1992;34:98-102.

Huynh DP, Pulst SM. Neurofibromatosis 2 antisense oligonucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene 1996;13:73-84.

Ikeda K, Ito H, Kashihara K, Fujisawa H, Yamamoto S. Effective preoperative irradiation of highly vascular cerebellopontine angle neurinomas. Neurosurgery 1988;22:566-73.

INTERPHONE Study Group. Acoustic neuroma risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Cancer Epidemiol 2011;35:453-64.

Irving RM, Jackler RK, Pitts LH. Hearing preservation in patients undergoing vestibular schwannoma surgery: comparison of middle fossa and retrosigmoid approaches. J Neurosurg 1998;88:840-5.

Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma. Arch Otolaryngol Head Neck Surg 1993;119:1222-8.

Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994;3:347-50.

Jackler RK, Pitts LH. Acoustic neuroma. Neurosurg Clin 1990;1:100-223.**

Jackler RK, Pitts LH. Selection of surgical approach to acoustic neuroma. Otolaryngol Clin North Am 1992;25:361-87.**

Jackowski A, Weiner G, O'Reilly G. Trochlear nerve schwannomas: a case report and literature review. Br J Neurosurg 1994;8:219-23.

Jacob A, Lee TX, Neff BA, Miller S, Welling B, Chang LS. Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma. Otol Neurotol 2008;29(1):58-68.

Jacob A, Robinson LL, Bortman JS, Yu L, Dodson EE, Welling DB. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center. Laryngoscope 2007;117(12):2087-92.

Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF. Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer 1996;17:45-55.

Jacoby LB, MacCollin M, Louis DN, et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-9.

Jung S, Kang SS, Kim TS, et al. Current surgical results of retrosigmoid approach in extralarge vestibular schwannomas. Surg Neurol 2000;53:370-8.

Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg 2009a;111(4):863-73.

Kano H, Niranjan A, Kondziolka D, Flickinger JC, Dade Lunsford L. Stereotactic radiosurgery for trigeminal schwannoma: tumor control and functional preservation. J Neurosurg 2009b;110(3):553-8.

Karpinos M, Teh BS, Zeck O, et al. Treatment of acoustic neuroma: stereotactic radiosurgery vs microsurgery. Int J Rad Oncol Biol Phys 2003;54(5):1410-21.

Karube K, Nabeshima K, Ishiguro M, Harada M, Iwasaki H. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol 2006;59:160-5.

Khurana VG, Teo C, Kundi M, Hardell L, Carlberg M. Cell phones and brain tumors: a review including the long-term epidemiologic data. Surg Neurol 2009;72(3):205-14.

Kim CS, Chang SO, Oh SH, Ahn SH, Hwang CH, Lee HJ. Management of intratemporal facial nerve schwannoma. Otol Neurotol 2003;24(2):312-6.

Kim DH, Murovic JA, Tiel RL, Moes G, Kline DG. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. J Neurosurg 2005;102:246-55.

Kim IY, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Gamma knife surgery for schwannomas originating from cranial nerves III, IV, and VI. J Neurosurg 2008;109 Suppl:149-53.

Kim SH, Youm JY, Song SH, Kim Y, Song KS. Vestibular schwannoma with repeated intratumoral hemorrhage. Clin Neurol Neurosurg 1998;100:68-74.

Kimura Y, Koga H, Araki N, et al. The involvement of caplain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Nature Med 1998;4:915-22.

King TT, Morrison AW. Translabyrinthine and transtentorial removal of acoustic nerve tumors. Results in 150 cases. J Neurosurg 1980;52:210-6.

Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC. Long-term outcomes after radiosurgery for acoustic neuromas. New Engl J Med 1998;339:1426-33.

Koutsimpelas D, Felmeden U, Mann WJ, Brieger J. Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization. J Neurooncol 2011;103(3):437-43.

Koutsimpelas D, Stripf T, Heinrich UR, Mann WJ, Brieger J. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics. Otol Neurotol 2007;28(8):1094-9.

Krishnamurthy S, Holmes B, Powers SK. Schwannomas limited to the infratemporal fossa: report of two cases. J Neurooncol 1998;36:269-77.

Lalwani AK. Meningiomas, epidermoids, and other nonacoustic tumors of the cerebellopontine angle. Otolaryngol Clin North Am 1992;25:707-28.

Lanman TH, Brackmann DE, Hitselberger WE, Subin B. Report of 190 consecutive cases of large acoustic tumors (vestibular schwannoma) removed via the translabyrinthine approach. J Neurosurg 1999;90:617-23.

Lanser MJ. Molecular genetics of acoustic tumors. Otolaryngol Clin 1992;25:995-1009.

LaSala PA, Frost EA, Boehm FH. Intracranial tumors. In: Frost EA, editor. Clinical anesthesia in neurosurgery. 2nd ed. Boston: Butterworth-Heinemann, 1991;10:245-63.

Lassaletta L, Bello MJ, Del Rio L, et al. DNA methylation of multiple genes in vestibular schwannoma: relationship with clinical and radiological findings. Otol Neurotol 2006;27(8):1180-5.

Lassaletta L, Patron M, Del Rio L, et al. Cyclin D1 expression and histopathologic features in vestibular schwannomas. Otol Neurotol 2007;28:939-41.

Lee LR, Gigantelli JW, Kincaid MC. Localized neurofibroma of the orbit. A radiographic and histopathologic study. Ophthal Plastic Reconstruc Surg 2000;16:241-6.

Lee TX, Packer MD, Huang J, et al. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Eur J Cancer 2009;45(9):1709-20.

Leveque-Lasource A. Observation sur un amaurosis et un cophosis, avec perte ou diminution de la voix, des mouvements, etc., par suite de lésion organique apparante de plusieurs parties du cerveau. J Gen Med Chir Pharm 1810;37:368-73.

Likhterov I, Allbright RM, Selesnick SH. LINAC radiosurgery and radiotherapy treatment of acoustic neuromas. Otolarngol Clin N Am 2007;40:541-70.

Lin J, Martel W. Cross-sectional imaging of peripheral nerve sheath tumors: characteristic signs on CT, MR imaging, and sonography. AJR 2001;176:75-82.

Linskey ME, Flickinger JC, Lunsford LD. Cranial nerve length predicts the risk of delayed facial and trigeminal neuropathies after acoustic tumor stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1993;25:227-33.

Linskey ME, Lunsford LD, Flickinger JC. Radiosurgery for acoustic neurinomas: early experience. Neurosurgery 1990;26:736-45.

Linskey ME, Lunsford LD, Flickinger JC, Kondziolka D. Stereotactic radiosurgery for acoustic tumors. Neurosurg Clin 1992;3:191-205.

Litre CF, Gourg GP, Tamura M, Roche PH, Regis J. Gamma knife surgery for facial nerve schwannomas. Prog Neurol Surg 2008;21:131-5.

Lodding P, Kindblom LG, Angervall L, Stenman G. Cellular schwannoma. A clinicopathologic study of 29 cases. Virchows Arch A Pathol Anat 1990;416:237-48.

Loeffler JS, Alexander E. The role of stereotactic radiosurgery in the management of intracranial tumors. Oncology 1990;4:21-31.

Louis DN, Edgerton S, Thor AD, Hedley-White ET. Proliferating cell nuclear antigen and Ki 67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol 1991;81:675-9.

Luetje CM. Spontaneous involution of acoustic tumors. Am J Otol 2000;21:393-8.

Lunsford LD, Linskey ME. Stereotactic radiosurgery in the treatment of patients with acoustic tumors. Otolaryngol Clin North Am 1992;25:471-91.

Lunsford LD, Niranjan A, Flickinger JC, Maitz A, Kondziolka D. Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg (Suppl) 2005;102:195-9.

Lusk MD, Kline DG, Garcia CA. Tumors of the brachial plexus. Neurosurgery 1987;21:439-53.

Lutchman M, Rouleau GA. Neurofibromatosis type 2: a new mechanism of tumor suppression. Trends Neurosci 1996;19:373-7.

Lye EH, Ramsden RT, Stack JP, Gellespie JE. Trigeminal nerve tumor: comparison of CT and MRI. Case report. J Neurosurg 1987;67:124-7.

Maartens NF, Ellegala DB, Vance ML, Lopes MB, Laws ER. Intrasellar schwannomas: Report of two cases. Neurosurg 2003;52:1200-6.

Macfarlane R, King TT. Acoustic neurinomas (vestibular schwannoma). In: Kaye AH, Laws ER, editors. Brain tumors. An encyclopedic approach. Edinburgh: Churchill Livingstone, 1995;31:577-622.**

Madhok R, Kondziolka D, Flickinger JC, Lunsford LD. Gamma knife radiosurgery for facial schwannomas. Neurosurgery 2009;64(6):1102-5.

Mafee MF. MR imaging of intralabyrinthine schwannoma, labyrinthitis, and other labyrinthine pathology. Otolaryngol Clin North Am 1995;28:407-30.

Mafee MF, Lachenauer CS, Kumar A, Arnold PM, Buckingham RA, Valvassori GE. CT and MR imaging of intralabyrinthine schwannoma: report of two cases and review of the literature. Radiology 1990;174:395-400.

Mariniello G, Horvat A, Dolenc VV. En bloc resection of an intracavernous oculomotor nerve schwannoma and grafting of the oculomotor nerve with sural nerve. Case report and review of the literature. J Neurosurg 1999;91:1045-9.

Martin J, Kondziolka D, Flickinger JC, Mathieu D, Niranjan A, Lunsford LD. Cranial nerve preservation and outcomes after stereotactic radiosurgery for jugular foramen schwannomas. Neurosurg 2007;61:76-81.

Martin TP, Tzifa K, Kowalski C, Holder RL, Walsh R, Irving RM. Conservative versus primary surgical treatment of acoustic neuromas: a comparison of rates of facial nerve and hearing preservation. Clin Otolaryngol 2008;33(3):228-35.

Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery 1997a;40:1-10.

Matthies C, Samii M. Management of vestibular schwannomas (acoustic neuromas): the value of neurophysiology for intraoperative monitoring of auditory function in 200 cases. Neurosurgery 1997b;40:459-68.

Matthies C, Samii M. Management of vestibular schwannomas (acoustic neuromas): the value of neurophysiology for evaluation and prediction of auditory function in 420 cases. Neurosurgery 1997c;40:919-30.

Mautner VF, Nguyen R, Kutta H, et al. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 2010;12(1):14-8.

Mawrin C, Kirches E, Boltze C, Dietzmann K. PTEN is not altered in sporadic vestibular schwannomas. Histopathology 2002;40:526-30.

Mawrin C, Schulz S, Hellwig-Patyk A, et al. Expression and function of somatostatin receptors in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 2005;64:1080-8.

McCormick PC, Bello JA, Post KD. Trigeminal schwannoma. Surgical series of 14 cases with review of the literature. J Neurosurg 1988;69:850-60.

McKenzie JD. Magnetic resonance imaging of cerebellopontine angle masses. BNI Q 1994;10:9-18.

Mehta VS, Singh RV, Misra NK, Choudhary C. Schwannoma of the oculomotor nerve. Br J Neurosurg 1990;4:69-72.

Meijer OW, Vandertop WP, Baayen JC, Slotman BJ. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study. Int J Rad Oncol Biol Phys 2003;56(5):1390-6.

Mendenhall WM, Friedman WA, Buatti JM, Bova FJ. Preliminary results of linear accelerator radiosurgery for acoustic schwannomas. J Neurosurg 1996;85:1013-9.

Miller NR. Tumors of cranial and peripheral nerves. In: Miller NR, editor. Walsh and Hoyt's clinical neuro-ophthalmology. Vol 3. 4th ed. Baltimore: Williams & Wilkins, 1988;50:1543-67.

Miller RC, Foote RL, Coffey RJ, et al. Decrease in cranial nerve complications after radiosurgery for acoustic neuromas: prospective study of dose and volume. Int J Radiat Oncol Biol Phys 1999;43:305-11.

Mirz F, Jorgensen B, Fiirgaard B, et al. Investigations into the natural history of vestibular schwannomas. Clin Otolaryngol 1999;24:13-8.

Moffat D, De R, Hardy D, Moumoulidis I. Surgical management of trigeminal neuromas: a report of eight cases. J Laryngol Otol 2006;120:631-7.

Moller MN, Werther K, Nalla A, et al. Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1. Laryngoscope 2010;120(4):657-62.

Monoh K, Ishikawa K, Yasue N, et al. p53 tumor suppressor gene in acoustic neuromas. Acta Otolaryngol 1998;537:11-5.

Moriyama T, Fukushima T, Asaoka K, Roche PH, Barrs DM, McElveen JT. Hearing preservation in acoustic neuroma surgery: importance of adhesion between the cochlear nerve and the tumor. J Neurosurg 2002;97:337-40.

Moulin G, Dessi P, Andre P, et al. Role of magnetic resonance imaging in predicting late facial motor function after removal of vestibular schwannomas by the translabyrinthine approach. J Laryngol Otol 1995;109(5):394-8.

Mukherjee J, Kamnasaran D, Balasubramaniam A, et al. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate). Cancer Res 2009;69(12):5099-107.

Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys 2011;15:985-97.

Muscat JE, Malkin MG, Shore RE, et al. Handheld cellular telephones and risk of acoustic neuroma. Neurology 2002;58:1304-6.

Myrseth E, Moller P, Pedersen PH, Lund-Johansen M. Vestibular schwannoma: surgery of gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 2009;64(4):654-63.

Nagano O, Higuchi Y, Serizawa T, et al. Transient expansion of vestibular schwannoma following stereotactic radiosurgery. J Neurosurg 2008;109(5):811-6.

Nedzelski JM, Schessel DA, Pfleiderer A, Kassel EE, Rowed DW. Conservative management of acoustic neuromas. Otolaryngol Clin North Am 1992;25:691-705.

Neff BA, Oberstien E, Lorenz M, et al. Cyclin D1 and D3 expression in vestibular schwannomas. Laryngoscope 2006;116:423-6.

Neff BA, Willcox TO, Sataloff RT. Intralabryinthine schwannomas. Otol Neurotol 2003;24:299-307.

Newton HB. Primary brain tumors: review of etiology, diagnosis, and treatment. Am Fam Physician 1994;49:787-97.

Newton HB, Newton CL, Gatens C, Hebert R, Pack R. Spinal cord tumors. Review of etiology, diagnosis, and multidisciplinary approach to treatment. Cancer Practice 1995;3:207-18.

Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and bromodeoxyuridine labeling indices in human brain tumors. J Neurosurg 1989;70:379-84.

Nishizaki T, Orita T, Saiki M, Furutani Y, Aoki H. Cell kinetics studies of human brain tumors in vitro labeling using anti-bromodeoxyuridine monoclonal antibody. J Neurosurg 1988;69:371-4.

Noren G, Arndt J, Hindmarsh T. Stereotactic radiosurgery in cases of acoustic neurinoma: further experiences. Neurosurgery 1983;13:12-22.

Nutik SL, Babb MJ. Determinants of tumor size and growth in vestibular schwannomas. J Neurosurg 2001;94:922-6.

Ogose A, Hotta T, Morita T, Otsuka H, Hirata Y. Multiple schwannomas in the peripheral nerves. J Bone Joint Surg Br 1998;80:657-61.

Ojemann RG. Retrosigmoid approach to acoustic neuroma (vestibular schwannoma). Neurosurg 2001;48:553-8.

Ojemann RG, Levine RA, Montgomery WM, McGaffigan P. Use of intraoperative auditory evoked potentials to preserve hearing in unilateral acoustic neuroma removal. J Neurosurg 1984;61:938-48.

Parisi JE, Mena H. Nonglial tumors. In: Nelson JS, Parisi JE, Schochet SS, editors. Principles and practice of neuropathology. St. Louis: Mosby, 1993;9:203-66.

Park SK, Yi HJ, Paik SS, Kim YJ, Ko Y, Oh SJ. Metastasizing malignant peripheral nerve sheath tumor initially presenting as intracerebral hemorrhage. Case report and review of the literature. Surg Neurol 2007;68(1):79-84.

Parmar H, Pang BC, Lim CC, Ching SM, Tan KK. Spinal schwannoma with acute subarachnoid hemorrhage: a diagnostic challenge. AJNR Am J Neuroradiol 2004;25(5):846-50.

Parmar H, Patkar D, Gadani S, Shah J. Cystic lumbar nerve sheath tumours: MRI features in five patients. Australas Radiol 2001;45:123-7.

Petronzelli F, Sollima D, Coppola G, Martini-Neri ME, Neri G, Genuardi M. CDKN2A germline splicing mutation affecting both p16ink4 and p14arf RNA processing in a melanoma/neurofibroma kindred. Genes Chromosomes Cancer 2001;31:398-401.

Phi JH, Paek SH, Chung HT, et al. Gamma knife surgery and trigeminal schwannoma: is it possible to preserve cranial nerve function? J Neurosurg 2007;107:727-32.

Pirouzmand F, Tator CH, Rutka J. Management of hydrocephalus associated with vestibular schwannoma and other cerebellopontine angle tumors. Neurosurg 2001;48:1246-54.

Plotkin SR, Halpin C, McKenna MJ, Loeffler JS, Batchelor TT, Barker FG 2nd. Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otol Neurotol 2010;31(7):1135-43.

Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. New Engl J Med 2009;361(4):358-67.

Pollack IF, Sekhar LN, Jannetta PJ, Janecka IP. Neurilemomas of the trigeminal nerve. J Neurosurg 1989;70:737-45.

Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: Treatment recommendations based on a 15 year experience. Neurosurg 2006;58:241-8.

Pollock BE, Driscoll CLW, Foote FL, et al. Patient outcomes after vestibular schwannoma management: A prospective comparison of microsurgical resection and stereotactic radiosurgery. Neuorsurg 2006;59:77-85.

Pollock BE, Foote RL, Stafford SL. Stereotactic radiosurgery: the preferred management for patients with nonvestibular schwannomas? Int J Radiat Oncol Biol Phys 2002;52:1002-7.

Pollock BE, Lunsford LD, Flickinger JC, Clyde BL, Kondziolka D. Vestibular schwannoma management. Part I. Failed microsurgery and the role of delayed stereotactic radiosurgery. J Neurosurg 1998a;89:944-8.

Pollock BE, Lunsford OD, Noren G. Vestibular schwannoma management in the next century: a radiosurgical perspective. Neurosurgery 1998b;43:475-83.

Prasad D, Steiner M, Steiner L. Gamma surgery for vestibular schwannoma. J Neurosurg 2000;92:745-9.

Prayson RA, Yoder BJ, Barnett GH. Epidermal growth factor receptor is not amplified in schwannomas. Ann Diagnost Pathol 2007;11:326-9.

Press GA, Hesselink JR. MR imaging of cerebellopontine angle and internal auditory canal lesions at 1.5 T. AJNR Am J Neuroradiol 1988;9:241-51.

Preuss M, Stein M, Huegens-Penzel M, Kuchelmeister K, Nestler U. Metastatic tumours mimicking vestibular schwannoma. Acta Neurochir (Wien) 2008;150(9):915-9.

Prochazka M, Feychting M, Ahlbom A, et al. Occupational exposures and risk of acoustic neuroma. Occup Environ Med 2010;67(11):766-71.

Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncol 2006;8:1-11.

Rapana A, Lamaida E, Bracale C, Lepore P, Pizza V, Graziussi G. Glossopharyngeal schwannoma, an uncommon posterior fossa tumor: diagnostical and therapeutical aspects: a case report. Clin Neurol Neurosurg 1997;99:196-8.

Regis J, Pellet W, Delsanti C, et al. Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J Neurosurg 2002;97:1091-100.

Repacholi MH, Lerchl A, Roosli M, et al. Systematic review of wireless phone use and brain cancer and other head tumors. Bioelectromagnet 2012;33(3):187-206.

Rey JA, Bello MJ, De Campos JM, Kusak ME, Moreno S. Cytogenetic analysis in human neurinomas. Cancer Genet Cytogenet 1987;28:187-8.

Rigamonti D, Spetzler RF, Shetter A, Drayer BP. Magnetic resonance imaging and trigeminal schwannoma. Surg Neurol 1987;28:67-70.

Rocchi G, Artico M, Lunardi P, Gagliardi FM. Intracranial schwannoma of the facial nerve: report of two cases and review of the literature. Neurochir 1991;34:180-3.

Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope 2000;110:497-508.

Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-21.

Rouleau GA, Wertelecki W, Haines JL, et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 1987;329:246-8.

Rubin DI, Matsumoto JY, Suarez GA, Auger RG. Facial trigeminal synkinesis associated with a trigeminal schwannoma. Neurology 1999;53:635-7.

Rubinstein AB, Reichenthal E, Borohov H. Radiation-induced schwannomas. Neurosurgery 1989;24:929-32.

Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th ed. Baltimore: Williams & Wilkins, 1989:533-89.

Russell SM. Preserve the nerve: Microsurgical resection of peripheral nerve sheath tumors. Neurosurg 2007;61:113-7.

Safavi-Abbasi S, Senoglu M, Theodore N, et al. Microsurgical management of spinal schwannomas: evaluation of 128 cases. J Neurosurg Spine 2008;9(1):40-7.

Sainz J, Figueroa K, Baser ME, Pulst SM. Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas. Hum Genet 1996;97:121-3.

Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 1994;3:885-91.

Sakamoto GT, Blevins N, Gibbs IC. Cyberknife radiotherapy for vestibular schannoma. Otolaryngol Clin North Am 2009;42(4):665-75.

Sakanaka K, Mizowaki T, Arakawa Y, et al. Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience. Int J Clin Oncol 2011;16(1):27-32.

Salvati M, Ciappetta, Raco A, Capone R, Artico M, Santoro A. Radiation-induced schwannomas of the neuraxis. Report of three cases. Tumori 1992;78:143-6.

Salzman KL, Davidson HC, Harnsberger HR, et al. Dumbbell schwannomas of the internal auditory canal. AJNR Am J Neuroradiol 2001;22:1368-76.

Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg 2006;105:527-35.

Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 1997a;40:11-23.

Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve- preservation and restitution of function. Neurosurgery 1997b;40:684-95.

Samii M, Migliori MM, Tatagiba M, Babu R. Surgical treatment of trigeminal schwannomas. J Neurosurg 1995;82:711-8.**

Sandifort E. Observationes anatomico pathologicae. Lugduni Batavorum 1777;9:116-20.

Sanguinetti C, Specchia N, Gigante A, de Palma L, Greco F. Clinical and pathological aspects of solitary spinal neurofibroma. J Bone Joint Surg 1993;75B:141-7.

Sanna M, Karmarkar S, Landolfi M. Hearing preservation in vestibular schwannoma surgery: fact or fantasy? J Laryngol Otol 1995;109:374-80.

Santoreneos S, Hanieh A, Jorgensen RE. Trochlear nerve schwannomas occurring in patients without neurofibromatosis: case report and review of the literature. Neurosurgery 1997;41:282-7.

Sarma S, Sekhar LN, Schessel DA. Nonvestibular schwannomas of the brain: A 7-year experience. Neurosurgery 2002;50:437-49.

Sawamura Y, Shirato H, Sakamoto T, et al. Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption. J Neurosurg 2003;99(4):685-92.

Schneider AB, Ron E, Lubin J, et al. Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck. Neuro Oncol 2008;10(1):73-8.

Schoemaker MJ, Swerdlow AJ, Ahlboom A, et al. Mobile phone use and risk of acoustic neuroma: results of the interphone case-control study in five North European countries. Br J Cancer 2005;93:842-8.

Schroth G, Thron A, Guhl L, Voight K, Niendorf HP, Garces LR. Magnetic resonance imaging of spinal meningiomas and neurinomas. Improvement of imaging by paramagnetic contrast enhancement. J Neurosurg 1987;66:695-700.

Schulze KM, Hanemann CO, Muller HW, Hanenberg H. Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis. Hum Mol Gen 2002;11:69-76.

Schuz J, Steding-Jessen M, Hansen S, et al. Long-term mobile phone use and the risk of vestibular schwannoma: a Danish nationwide cohort study. Am J Epidemiol 2011;174:416-22.

Seizinger BR, Martuza RL, Gusella JF. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 1986;322:644-7.

Selesnick SH, Jackler RK. Clinical manifestations and audiologic diagnosis of acoustic neuromas. Otolaryngol Clin North Am 1992;25:521-51.**

Seol HJ, Jung HW, Park SH, et al. Aggressive vestibular schwannomas showing postoperative rapid growth - their association with decreased p27 expression. J Neuro-Oncol 2005;75:203-7.

Seppala MT, Haltia MJ, Sankila RJ, Jaaskelainen JE, Heiskanen O. Long-term outcome after removal of spinal neurofibroma. J Neurosurg 1995a;82:572-7.

Seppala MT, Haltia MJ, Sankila RJ, Jaaskelainen JE, Heiskanen O. Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg 1995b;83:621-6.**

Sharma RR, Gurusinghe NT, Lynch PG, Parekh HC, Bertolis G. Intraparenchymatous schwannoma of the cerebellum. Br J Neurosurg 1993;7:83-90.

Sharma S, Abbott RI, Zagzag D. Malignanta intracerebral nerve sheath tumor. A case report and review of the literature. Cancer 1998;82:545-52.

Shetter AG. Gamma knife radiosurgery for the treatment of acoustic neuromas. BNI Quart 1997;13:30-6.

Singh RV, Suys S, Campbell DA, Broome JC. Malignant schwannoma of the cerebellum: case report. Surg Neurol 1993;39:128-32.

Skovronsky DM, Oberholtzer JC. Pathologic classification of peripheral nerve tumors. Neurosurg Clin N Am 2004;15(2):157-66.

Slattery WH 3rd, Fisher LM, Yoon G, Sorensen G, Lev M. Magnetic resonance imaging scanner reliability for measuring changes in vestibular schwannoma size. Otol Neurotol 2003;24(4):666-70.

Sluyter S, Graamans K, Tulleken CAF, Van Veelen WM. Analysis of the results obtained in 120 patients with large acoustic neuromas surgically treated via the translabyrinthine-transtentorial approach. J Neurosurg 2001;94:61-6.

Smirniotopoulos JG, Yue NC, Rushing EJ. Cerebellopontine angle masses: radiologic-pathologic correlation. Radiographics 1993;13:1131-47.**

Son JM, Ahn MI, Cho KD, Yoo J, Park YH. Varying degrees of FDG update in multiple benign neurofibromas on PET/CT. Br J Radiol 2007;80:e222-6.

Sordillo PP, Helson L, Hajdu SI, et al. Malignant schwannoma- clinical characteristics, survival, and response to therapy. Cancer 1981;47:2503-9.

Spiegelmann R, Lidar Z, Gofman J, Alezra D, Hadani M, Pfeffer R. Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg 2001;94:7-13.

Sridhar K, Ramamurthi R, Vasudevan MC, Ramamurthi B. Giant invasive spinal schwannomas: definition and surgical management. J Neurosurg (Spine 2) 2001;94:210-5.

Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, et al. Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 1997;151:1649-54.

Strauss C. The facial nerve in medial acoustic neuromas. J Neurosurg 2002;97:1083-90.

Strauss R, Post KD. Other schwannomas of cranial nerves. In: Kaye AH, Laws ER, editors. Brain tumors. An encyclopedic approach. Edinburgh: Churchill Livingstone, 1995;33:643-64.**

Sughrue ME, Yang I, Aranda D, et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg 2010;112(1):163-7.

Suh JH, Barnett GH, Sohn JW, Kupelian PA, Cohen BH. Results of linear accelerator-based stereotactic radiosurgery for recurrent and newly diagnosed acoustic neuromas. Int J Cancer 2000;90:145-51.

Surace EI, Haipek CA, Gutmann DH. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene 2004;23(2):580-7.

Swan IR. Is early management of acoustic neuroma important? J R Soc Med 2000;93:614-7.

Sweasey TA, Edelstein SR, Hoff JT. Glossopharyngeal schwannoma: review of five cases and the literature. Surg Neurol 1991;35:127-30.

Szumacher E, Schwartz ML, Tsao M, et al. Fractionated stereotactic radiotherapy for the treatment of vestibular schwannomas: Combined experience of the Toronto-Sunnybrook regional cancer centre and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 2002;53:987-91.

Tago M, Terahara A, Nakagawa K, et al. Immediate neurological deterioration after gamma knife radiosurgery for acoustic neuroma. Case report. J Neurosurg 2000;93:78-81.

Taha JM, Tew JM, van Lovern HR, Keller JT, El-Kalliny M. Comparison of conventional and skull base surgical approaches for the excision of trigeminal neurinomas. J Neurosurg 1995;82:719-25.

Thomas R, Prabhu PD, Mathivanan J, et al. Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas. Mol Cell Biochem 2005;271:113-21.

Thomsen J, Tos M. Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol 1990;11:12-9.

Timmer FC, Hanssens PE, van Haren AE, et al. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Laryngoscope 2009;119(6):1076-81.

Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800.

Tucker A, Miyake H, Tsuji M, Ukita T, Nishihara K, Ohmura T. Intradural microsurgery and extradural gamma knife surgery for hypoglossal schwannoma: case report and review of the literature. Minim Invasive Neurosurg 2007;50(6):374-8.

Tung H, Chen T, Weiss MH. Sixth nerve schwannomas. Report of two cases. J Neurosurg 1991;75:638-41.

Twist EC, Ruttledge MH, Tousseau M, et al. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 1994;3:147-51.

Uesaka T, Shono T, Suzuki SO, et al. Expression of VEGF and its receptor genes in intracranial schwannomas. J Neuro-Oncol 2007;83:259-66.

Utermark T, Kaemphchen K, Antoniadis G, Hanemann CO. Reduced apoptosis rates in human schwannomas. Brain Pathol 2005;15:17-22.

Utermark T, Kaempchen K, Hanemann CO. Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins. Brain Pathol 2003;13(3):352-63.

Von Monakow. Eber neurofibroma der hinteren schadelgrube. Berl Klin Wsachr 1900;37:721-4.

Vorasubin N, Sang U H, Mafee M, Nguyen QT. Glossopharyngeal schwannomas: a 100 year review. Laryngoscope 2009;119(1):26-35.

Wackym PA, King WA, Poe DS, et al. Adjunctive use of endoscopy during acoustic neuroma surgery. Laryngoscope 1999;109:1193-201.

Wallner KE, Sheline GE, Pitts LH, Wara WM, Davis RL, Boldrey EB. Efficacy of irradiation for incompletely excised acoustic neurilemomas. J Neurosurg 1987;67:858-63.

Wanibuchi M, Fukushima T, McElveen JT Jr, Friedman AH. Hearing preservation in surgery for large vestibular schwannomas. J Neurosurg 2009;111(4):845-54.

Wasa J, Nishida Y, Suzuki Y, et al. Differential expression of angiogenic factors in peripheral nerve sheath tumors. Clin Exp Metastasis 2008;25(7):819-25.

Wazen J, Silverstein H, Norrell H, Besse B. Preoperative and postoperative growth rates in acoustic neuromas documented with CT scanning. Otolaryngol Head Neck Surg 1985;93:151-5.

Webb HD, Griffin CA. Cytogenetic study of acoustic neuroma [letter]. Cancer Genet Cytogenet 1991;56(1):83-4.

Weber AL, McKenna MJ. Radiologic evaluation of the jugular foramen. Anatomy, vascular variants, anomalies, and tumors. Neuroimag Clin North Am 1994;4:579-98.

Weber DC, Chan AW, Bussiere MR, et al. Proton beam radiosurgery for vestibular schwannoma: Tumor control and cranial nerve toxicity. Neurosurg 2003;53(3):577-86.

Welling DB. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas). Laryngoscope 1998;108:178-89.

Welling DB, Glasscock ME, Woods CI, Jackson CG. Acoustic neuroma: a cost-effective approach. Otolaryngol Head Neck Surg 1990;103:364-70.

Welling DB, Guida M, Goll F, et al. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Hum Genet 1996;98:189-93.

Welling DB, Packer MD, Chang LS. Molecular studies of vestibular schwannomas: a review. Curr Opin Otolaryngol Head Neck Surg 2007;15:341-6.

White W, Shiu MH, Rosenblum MK, Erlandson RA, Woodruff JM. Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors. Cancer 1990;66:1266-75.

Wickremesekera A, Hovens CM, Kaye AH. Expression of ErbB-1 and 2 in vestibular schwannomas. J Clin Neurosci 2007;14(12):1199-206.

Widemann BC. Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Curr Oncol Rep 2009;11(4):322-8.

Wiet RJ, Teixido M, Liang JG. Complications in acoustic neuroma surgery. Otolaryngol Clin N Am 1992;25(2):389-412.

Wilson MA, Hillman TA, Wiggins RH, Shelton C. Jugular foramen schwannomas: Diagnosis, management, and outcomes. Laryngoscope 2005;115:1486-92.

Wong HK, Lahdenranta J, Kamoun WS, et al. Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. Cancer Res 2010;70(9):3483-93.

Xiao GH, Chernoff J, Testa JR. NF2: the wizardry of merlin. Genes Chromosomes Cancer 2003;38(4):389-99.

Yang I, Sughrue ME, Han SJ, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg 2010;112(4):851-9.

Yingling CD, Gardi JN. Intraoperative monitoring of facial and cochlear nerves during acoustic neuroma surgery. Otolaryngol Clin North Am 1992;25:413-48.

Yong RL, Westerberg BD, Dong C, Akagami R. Length of tumor-cochlear nerve contact and hearing outcome after surgery for vestibular schwannoma. J Neurosurg 2008;108(1):105-10.

Yoshida K, Kawase T. Trigeminal neurinomas extending into multiple fossae: surgical methods and review of the literature. J Neurosurg 1999;91:202-11.

Yuh WT, Wright DC, Barloon TJ, Schultz DH, Sato Y, Cervantes CA. MR imaging of primary tumors of trigeminal nerve and Meckel's cave. AJR Am J Roentgenol 1988;151:577-82.

Zabel A, Debus J, Thilmann C, Schlegel W, Wannenmacher M. Management of benign cranial nonacoustic schwannomas by fractionated stereotactic radiotherapy. Int J Cancer 2001;96:356-62.

Zealley IA, Cooper RC, Clifford KM, et al. MRI screening for acoustic neuroma: a comparison of fast spin echo and contrast enhanced imaging in 1233 patients. Br J Radiol 2000;73:242-7.

Zhang L, Yang Y, Xu S, Wang J, Liu Y, Zhu S. Trigeminal schwannomas: a report of 42 cases and review of the relevant surgical approaches. Clin Neurol Neurosurg 2009;111(3):261-9.

Zhang N, Pan L, Dai JZ, Wang BJ, Wang EM, Cai PW. Gamma knife radiosurgery for jugular foramen schwannomas. J Neurosurg (Suppl 5) 2002;97:456-8.

Zou C, Smith KD, Liu J, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 2009a;249(6):1014-22.

Zou CY, Smith KD, Zhu QS, et al. Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther 2009b.

**References especially recommended by the author or editor for general reading.

In This Article

Historical note and nomenclature
Clinical manifestations
Clinical vignette
Pathogenesis and pathophysiology
Differential diagnosis
Diagnostic workup
Prognosis and complications
References cited